4//SEC Filing
Dunsire Deborah 4
Accession 0001209191-23-033718
CIK 0001556263other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:23 PM ET
Size
8.3 KB
Accession
0001209191-23-033718
Insider Transaction Report
Form 4
Dunsire Deborah
Director
Transactions
- Award
Restricted Stock Units
2023-06-01+4,000→ 4,000 total→ Common Stock (4,000 underlying) - Award
Stock Option (right to buy)
2023-06-01+6,000→ 6,000 totalExercise: $3.70Exp: 2033-05-31→ Common Stock (6,000 underlying)
Footnotes (3)
- [F1]The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments of 8.33% of the shares underlying the award until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date.
- [F2]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
- [F3]These RSUs will vest in their entirety on the earlier to occur of (i) the first anniversary of the date of grant of the award, or (ii) the date of the Company's next Annual Meeting of Stockholders, subject in each case to the director's continued service as a director through the applicable vesting date.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001332764
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:23 PM ET
- Size
- 8.3 KB